River Street Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,945
Closed -$300K 180
2026
Q1
$300K Buy
+4,945
New +$288K 0.1% 142
2024
Q1
Sell
-9,714
Closed -$498K 131
2023
Q4
$498K Sell
9,714
-1,982
-17% -$104K 0.4% 75
2023
Q3
$679K Buy
11,696
+526
+5% +$32.2K 0.64% 52
2023
Q2
$714K Sell
11,170
-255
-2% -$17.1K 0.68% 50
2023
Q1
$792K Buy
11,425
+276
+2% +$19.5K 0.78% 42
2022
Q4
$802K Buy
+11,149
New +$841K 0.86% 40

Other funds holding BMY

River Street Advisors's BMY Position: Q2 2026 in Review

River Street Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 4,945 shares — an estimated $300K sold.

River Street Advisors first reported a position in BMY in Q4 2022 and held it in 6 quarters. The position peaked at $802K in Q4 2022. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • River Street Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • River Street Advisors sold 4,945 Bristol-Myers Squibb shares in Q2 2026, an estimated $300K.
  • River Street Advisors first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 6 quarters.
  • River Street Advisors's Bristol-Myers Squibb position peaked at $802K in Q4 2022.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on River Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.